Keytruda Injection | Pembrolizumab | Immunotherapy | Oncology Medicine Supplier
Keytruda Injection contains Pembrolizumab, a monoclonal antibody used in cancer immunotherapy. It works by blocking the PD-1 pathway, helping the immune system recognize and attack cancer cells under medical supervision.
🔍 Keywords
Pembrolizumab Injection, Keytruda Supplier, Immunotherapy Drug, PD-1 Inhibitor, Cancer Treatment Medicine, Oncology Injection Exporter
🔹 Product Category
Oncology Medicine | Immunotherapy | Monoclonal Antibody
🔹 Composition
Pembrolizumab (strength as per COA)
🔹 Uses / Indications
✔ Non-Small Cell Lung Cancer (NSCLC)
✔ Melanoma
✔ Head and Neck Cancer
✔ Urothelial carcinoma
✔ Other cancers (as prescribed)
🔹 Key Benefits
✔ Enhances immune response against cancer
✔ Targeted immunotherapy approach
✔ Improves survival outcomes
✔ Widely used in advanced oncology
🔹 Dosage & Administration
✔ Intravenous infusion
✔ Administered under oncologist supervision
✔ Dosage as per treatment protocol
🔹 Packaging & Supply
✔ Vial Injection
✔ Cold-chain export packaging available
✔ Bulk supply supported
🔹 Storage Instructions
✔ Store at 2–8°C
✔ Do not freeze
✔ Protect from light
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Global Export Supply
USA, UK, UAE, Singapore, India, Philippines, Vietnam, South Africa, Nigeria, Kenya, Brazil, Mexico, Peru
📍 Location: Nagpur, Maharashtra, India
📞 Contact for Bulk Orders
+91 8007161282
+91 9970011496
📧 Email: sales@pacificmedicines.com
🔖 Hashtags
#Pembrolizumab #Keytruda #Immunotherapy #CancerTreatment #Oncol
